左心室辅助装置植入后急性肾损伤:当代见解与未来展望
本文综述左心室辅助装置(LVAD)植入后急性肾损伤(AKI)的定义、诊断、发生率、病理生理和危险因素,并探讨预防与管理策略。LVAD植入量快速增长,尤其作为目的地治疗的患者年龄更大、合并症更多、肾功能受损,术后风险更高,需优化围术期管理以识别高危患者并预防AKI等严重并发症。
要点
- LVAD植入后AKI常见,与高发病率和死亡率相关。
- 目的地治疗患者年龄更大、合并症负担更高、肾功能受损,术后风险增加。
- 需优化围术期管理,识别高危患者并预防AKI。
核心结论
- LVAD植入后AKI是常见并发症,与高发病率和死亡率相关,需改进高危患者识别和围术期管理以预防严重并发症。
研究设计与样本
- 综述,概述LVAD患者AKI的定义、诊断、发生率、病理生理、危险因素及预防管理策略。
主要发现
- LVAD植入量快速增长,作为目的地治疗的患者通常年龄更大、合并症负担更高、肾功能受损且术后风险增加。
临床怎么用
- 临床应关注LVAD植入后AKI的预防与管理,优化围术期管理并识别高危患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Currently, an increasing number of patients with end-stage heart failure are being treated with left ventricular assist device (LVAD) therapy as bridge-to-transplantation, bridge-to-candidacy, or destination therapy (DT). Potential life-threatening complications may occur, specifically in the early post-operative phase, which positions LVAD implantation as a high-risk surgical procedure. Acute kidney injury (AKI) is a frequently observed complication after LVAD implantation and is associated with high morbidity and mortality. The rapidly growing number of LVAD implantations necessitates better approaches of identifying high-risk patients, optimizing peri-operative management, and preventing severe complications such as AKI. This holds especially true for those patients receiving an LVAD as DT, who are typically older (with higher burden of comorbidities) with impaired renal function and at increased post-operative risk. Herein we outline the definition, diagnosis, frequency, pathophysiology, and risk factors for AKI in patients with an LVAD. We also review possible strategies to prevent and manage AKI in this patient population.
引用
- Yalcin YC, Bunge JJH, Guven G, et al. Acute kidney injury following left ventricular assist device implantation: Contemporary insights and future perspectives. J Heart Lung Transplant. 2019. PMID: 31352996. doi:10.1016/j.healun.2019.06.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。